Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL: 4013)
Saudi Arabia
· Delayed Price · Currency is SAR 275.40
-1.40 (-0.51%)
Dec 3, 2024, 3:18 PM AST
Dr. Sulaiman Al Habib Medical Services Group Company Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Revenue | 10,558 | 9,508 | 8,311 | 7,250 | 5,862 | 5,016 | Upgrade
|
| Revenue Growth (YoY) | 13.83% | 14.41% | 14.62% | 23.69% | 16.85% | 9.34% | Upgrade
|
| Cost of Revenue | 6,959 | 6,255 | 5,578 | 4,934 | 4,009 | 3,502 | Upgrade
|
| Gross Profit | 3,599 | 3,254 | 2,733 | 2,316 | 1,853 | 1,515 | Upgrade
|
| Selling, General & Admin | 1,333 | 1,158 | 1,032 | 850.28 | 737.94 | 646.98 | Upgrade
|
| Operating Expenses | 1,333 | 1,158 | 1,032 | 850.28 | 737.94 | 646.98 | Upgrade
|
| Operating Income | 2,266 | 2,096 | 1,700 | 1,466 | 1,115 | 867.72 | Upgrade
|
| Interest Expense | -106.87 | -70.11 | -49.36 | -37.9 | -48.5 | -27.96 | Upgrade
|
| Interest & Investment Income | 82.13 | 82.13 | 40.72 | 9.9 | 13.05 | 20.51 | Upgrade
|
| Earnings From Equity Investments | 24.98 | 22.18 | 19.61 | 7.49 | 1.84 | 1.54 | Upgrade
|
| Other Non Operating Income (Expenses) | 38.8 | 40.14 | 85.2 | 55.7 | 46.55 | 41.46 | Upgrade
|
| EBT Excluding Unusual Items | 2,305 | 2,170 | 1,797 | 1,501 | 1,128 | 903.27 | Upgrade
|
| Pretax Income | 2,305 | 2,170 | 1,797 | 1,501 | 1,128 | 903.27 | Upgrade
|
| Income Tax Expense | 22.24 | 68.52 | 107.71 | 114.07 | 92.79 | 65.68 | Upgrade
|
| Earnings From Continuing Operations | 2,283 | 2,101 | 1,689 | 1,387 | 1,035 | 837.6 | Upgrade
|
| Minority Interest in Earnings | -56.59 | -55.46 | -38.2 | -10.66 | 20.47 | 32.64 | Upgrade
|
| Net Income | 2,227 | 2,046 | 1,651 | 1,377 | 1,055 | 870.23 | Upgrade
|
| Net Income to Common | 2,227 | 2,046 | 1,651 | 1,377 | 1,055 | 870.23 | Upgrade
|
| Net Income Growth | 13.45% | 23.94% | 19.91% | 30.43% | 21.29% | 8.60% | Upgrade
|
| Shares Outstanding (Basic) | 350 | 350 | 350 | 350 | 350 | 350 | Upgrade
|
| Shares Outstanding (Diluted) | 350 | 350 | 350 | 350 | 350 | 350 | Upgrade
|
| EPS (Basic) | 6.36 | 5.85 | 4.72 | 3.93 | 3.02 | 2.49 | Upgrade
|
| EPS (Diluted) | 6.36 | 5.85 | 4.72 | 3.93 | 3.02 | 2.49 | Upgrade
|
| EPS Growth | 13.45% | 23.94% | 19.91% | 30.43% | 21.29% | 8.60% | Upgrade
|
| Free Cash Flow | -612.88 | -252.74 | 1,330 | 929.27 | 1,420 | 326.2 | Upgrade
|
| Free Cash Flow Per Share | -1.75 | -0.72 | 3.80 | 2.66 | 4.06 | 0.93 | Upgrade
|
| Dividend Per Share | 4.690 | 4.320 | 3.480 | 2.800 | 2.100 | - | Upgrade
|
| Dividend Growth | 14.39% | 24.14% | 24.29% | 33.33% | - | - | Upgrade
|
| Gross Margin | 34.09% | 34.22% | 32.88% | 31.95% | 31.61% | 30.20% | Upgrade
|
| Operating Margin | 21.47% | 22.04% | 20.46% | 20.22% | 19.02% | 17.30% | Upgrade
|
| Profit Margin | 21.09% | 21.52% | 19.86% | 18.99% | 18.01% | 17.35% | Upgrade
|
| Free Cash Flow Margin | -5.80% | -2.66% | 16.01% | 12.82% | 24.23% | 6.50% | Upgrade
|
| EBITDA | 2,582 | 2,358 | 1,960 | 1,728 | 1,378 | 1,074 | Upgrade
|
| EBITDA Margin | 24.46% | 24.80% | 23.59% | 23.84% | 23.51% | 21.41% | Upgrade
|
| D&A For EBITDA | 315.75 | 262.57 | 259.77 | 262.11 | 263.23 | 206.03 | Upgrade
|
| EBIT | 2,266 | 2,096 | 1,700 | 1,466 | 1,115 | 867.72 | Upgrade
|
| EBIT Margin | 21.47% | 22.04% | 20.46% | 20.22% | 19.02% | 17.30% | Upgrade
|
| Effective Tax Rate | 0.96% | 3.16% | 5.99% | 7.60% | 8.23% | 7.27% | Upgrade
|
| Advertising Expenses | - | 35.72 | 32.82 | 22.79 | 17.8 | 24.59 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.